Cervarix

Cervarix is a bivalent HPV vaccine by GlaxoSmithKline that protects against Human Papillomavirus types 16 and 18, the most common causes of cervical cancer. Recommended for girls and women aged 9–45 years.

• ✓Protects against HPV types 16 & 18 (70% of cervical cancers)
• ✓AS04 adjuvant system for strong, long-lasting immunity
• ✓Approved for girls from age 9 years
• ✓Cross-protection against additional HPV strains

Requires 2 doses